Trends in the treatment and survival of pancreatic cancer: analysis of 23,339 patients diagnosed between 2010 and 2017

Introduction With a rising incidence and unchanged poor prognosis, pancreatic cancer is increasingly becoming a focus of gastroenterological oncology, but there is a lack of real-world data. The aim of the current study was to investigate trends in survival and treatment patterns by analyzing German...

Full description

Saved in:
Bibliographic Details
Main Authors: Damm, Marko (Author) , Heinig, Miriam (Author) , Rosendahl, Jonas (Author) , Michl, Patrick (Author) , Haug, Ulrike (Author) , Krug, Sebastian (Author)
Format: Article (Journal)
Language:English
Published: 19 September 2025
In: Cancer medicine
Year: 2025, Volume: 14, Issue: 18, Pages: 1-11
ISSN:2045-7634
DOI:10.1002/cam4.71248
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/cam4.71248
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.71248
Get full text
Author Notes:Marko Damm, Miriam Heinig, Jonas Rosendahl, Patrick Michl, Ulrike Haug, Sebastian Krug

MARC

LEADER 00000caa a2200000 c 4500
001 1938981839
003 DE-627
005 20260203142333.0
007 cr uuu---uuuuu
008 251021s2025 xx |||||o 00| ||eng c
024 7 |a 10.25673/121287  |2 doi 
024 7 |a 10.1002/cam4.71248  |2 doi 
035 |a (DE-627)1938981839 
035 |a (DE-599)KXP1938981839 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Damm, Marko  |d 1987-  |e VerfasserIn  |0 (DE-588)1073266249  |0 (DE-627)82874548X  |0 (DE-576)43477944X  |4 aut 
245 1 0 |a Trends in the treatment and survival of pancreatic cancer  |b analysis of 23,339 patients diagnosed between 2010 and 2017  |c Marko Damm, Miriam Heinig, Jonas Rosendahl, Patrick Michl, Ulrike Haug, Sebastian Krug 
264 1 |c 19 September 2025 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.02.2026 
520 |a Introduction With a rising incidence and unchanged poor prognosis, pancreatic cancer is increasingly becoming a focus of gastroenterological oncology, but there is a lack of real-world data. The aim of the current study was to investigate trends in survival and treatment patterns by analyzing German health claims data. Methods Pancreatic cancer patients diagnosed between 2010 and 2017 were identified from the German Pharmacoepidemiological Research Database (GePaRD, approximately 20% of the German population). Data on demographics, tumor treatment within 1 year after diagnosis, and survival were extracted. Results The study population comprised 23,339 patients with a median age of 74 years (IQR 66-80) and 44% with localized and 56% with metastatic disease. Overall, 52.4% received any chemotherapy, and curative intended resection was performed in 28.3%. Neoadjuvant and adjuvant therapy were performed in 4.4% and 58.7% of the cases, respectively. The median overall survival of the whole study population was 7.84 months. Patients diagnosed in the most recent period (2014-2017) had a significantly better prognosis (8.20 months (95% CI 7.97-8.43)) than patients who were diagnosed in the earlier period (2010-2013) (7.54 months (95% CI 7.31-7.70), p < 0.001), with an age-, sex-, and stage-adjusted hazard ratio of 0.87 (95% CI 0.85-0.9). Over time, the most pronounced treatment trends have affected patients with localized disease, with increasing frequency of resection and neoadjuvant therapy and decreasing frequency of best supportive care. Conclusion This comprehensive insight into survival and treatment of pancreatic cancer in Germany shows presumably medically beneficial therapy trends with, however, only marginal improvements in prognosis to date. 
540 |q DE-3  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
650 4 |a chemotherapy 
650 4 |a epidemiology 
650 4 |a pancreatic cancer 
650 4 |a resection 
650 4 |a survival 
700 1 |a Heinig, Miriam  |e VerfasserIn  |4 aut 
700 1 |a Rosendahl, Jonas  |d 1977-  |e VerfasserIn  |0 (DE-588)1020755024  |0 (DE-627)69133434X  |0 (DE-576)361950845  |4 aut 
700 1 |a Michl, Patrick  |d 1971-  |e VerfasserIn  |0 (DE-588)121336328  |0 (DE-627)081239203  |0 (DE-576)292654677  |4 aut 
700 1 |a Haug, Ulrike  |d 1975-  |e VerfasserIn  |0 (DE-588)131976702  |0 (DE-627)516330152  |0 (DE-576)29887217X  |4 aut 
700 1 |a Krug, Sebastian  |d 1985-  |e VerfasserIn  |0 (DE-588)1014103975  |0 (DE-627)705168034  |0 (DE-576)348318332  |4 aut 
773 0 8 |i Enthalten in  |t Cancer medicine  |d Hoboken, NJ : Wiley, 2012  |g 14(2025), 18 vom: Sept., Artikel-ID e71248, Seite 1-11  |h Online-Ressource  |w (DE-627)71860153X  |w (DE-600)2659751-2  |w (DE-576)366682164  |x 2045-7634  |7 nnas  |a Trends in the treatment and survival of pancreatic cancer analysis of 23,339 patients diagnosed between 2010 and 2017 
773 1 8 |g volume:14  |g year:2025  |g number:18  |g month:09  |g elocationid:e71248  |g pages:1-11  |g extent:11  |a Trends in the treatment and survival of pancreatic cancer analysis of 23,339 patients diagnosed between 2010 and 2017 
856 4 0 |u https://doi.org/10.1002/cam4.71248  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.71248  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260203 
993 |a Article 
994 |a 2025 
998 |g 1014103975  |a Krug, Sebastian  |m 1014103975:Krug, Sebastian  |d 910000  |d 910100  |e 910000PK1014103975  |e 910100PK1014103975  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 121336328  |a Michl, Patrick  |m 121336328:Michl, Patrick  |d 50000  |e 50000PM121336328  |k 0/50000/  |p 4 
999 |a KXP-PPN1938981839  |e 4874858392 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 03.02.2026"],"recId":"1938981839","person":[{"family":"Damm","role":"aut","display":"Damm, Marko","given":"Marko"},{"family":"Heinig","role":"aut","given":"Miriam","display":"Heinig, Miriam"},{"given":"Jonas","display":"Rosendahl, Jonas","role":"aut","family":"Rosendahl"},{"family":"Michl","role":"aut","given":"Patrick","display":"Michl, Patrick"},{"family":"Haug","role":"aut","display":"Haug, Ulrike","given":"Ulrike"},{"role":"aut","family":"Krug","display":"Krug, Sebastian","given":"Sebastian"}],"language":["eng"],"name":{"displayForm":["Marko Damm, Miriam Heinig, Jonas Rosendahl, Patrick Michl, Ulrike Haug, Sebastian Krug"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"19 September 2025"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2659751-2"],"issn":["2045-7634"],"eki":["71860153X"]},"title":[{"title_sort":"Cancer medicine","title":"Cancer medicine"}],"origin":[{"publisherPlace":"Hoboken, NJ","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisher":"Wiley"}],"recId":"71860153X","disp":"Trends in the treatment and survival of pancreatic cancer analysis of 23,339 patients diagnosed between 2010 and 2017Cancer medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"text":"14(2025), 18 vom: Sept., Artikel-ID e71248, Seite 1-11","pages":"1-11","extent":"11","issue":"18","volume":"14","year":"2025"},"language":["eng"],"pubHistory":["1.2012 -"],"note":["Gesehen am 07.05.13"]}],"physDesc":[{"noteIll":"Diagramme","extent":"11 S."}],"id":{"doi":["10.25673/121287","10.1002/cam4.71248"],"eki":["1938981839"]},"title":[{"subtitle":"analysis of 23,339 patients diagnosed between 2010 and 2017","title":"Trends in the treatment and survival of pancreatic cancer","title_sort":"Trends in the treatment and survival of pancreatic cancer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a DAMMMARKOHTRENDSINTH1920